About us

Research and products:

Biological Drug candidate HAS2021 is based on Primecell´s fifteen years experience with cell and tissue products and extraordinary orthopedics outputs of University hospital in Prague.

Cytokine Bioscience is a spin-off of Primecell´s research labs 4MEDi and NATIC, similarly as a spin-off Biohealing (2018).

Research of HAS2021 was granted by the Technology Agency of the Czech Republic, ID Trend1/FW01010339 in 2019.

Project INNOBOOSTER: Global Business Development Officer is co-financed by the Moravian-Silesian Region within the framework of the grant program Support for Entrepreneurship in the Moravian-Silesian Region 2022.

Cytokine financing round A
https://cytokinebio.com/cytokine-financing-round-a/

Leadership

Prof. Martin Krbec, MD, Ph.D.

Head of orthopedic clinic University hospital, Vice-chairman of Orthopedic society

Prof. Valer Dzupa, MD

Vice dean School of medicine,
Charles University Prague

MSc. Iveta Schmiedova

Head of the project, Statutary representative of Cytokine

20230119_145121_2

MSc. Lucia Pistorova

Quality manager

ZUM

MSc. Zuzana Maceckova, Ph.D.

Head of Research

MSc. Michal Zahradnicek, MBA

Founder
Biomed enterpreneur venture,
4MEDI biotech accelerator